Bevacizumab therapy for adults with recurrent/progressive meningioma: A retrospective series

Journal of Neuro-Oncology

Volumn 109, Issue 1, 2012, Pages 63-70

  Lou, Emil ^a,b   Sumrall, Ashley L ^a   Turner, Scott ^a   Peters, Katherine B ^a   Desjardins, Annick ^a   Vredenburgh, James J ^a   McLendon, Roger E ^a   Herndon II, James E ^a   McSherry, Frances ^a   Norfleet, Julie ^a   Friedman, Henry S ^a   Reardon, David A ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Bevacizumab; Meningioma; Vascular endothelial growth factor

Indexed keywords

ALPHA INTERFERON; BEVACIZUMAB; ERLOTINIB; ETOPOSIDE; GEFITINIB; HYDROXYUREA; IMATINIB; IRINOTECAN; MIFEPRISTONE; OCTREOTIDE; RAPAMYCIN; TAMOXIFEN; TEMOZOLOMIDE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN HEMORRHAGE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CELLULITIS; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; INTESTINE PERFORATION; MALE; MENINGIOMA; PROGRESSION FREE SURVIVAL; PROTEINURIA; RECTUM HEMORRHAGE; RECURRENT DISEASE; RETROSPECTIVE STUDY; THROMBOCYTOPENIA;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84864290596     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0861-0     Document Type: Article

References (42)

1. CBTRUS (2010) CBTRUS: 2010 statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004-2006
2. C Mawrin A Perry 2010 Pathological classification and molecular genetics of meningiomas J Neurooncol 99 379 391 10.1007/s11060-010-0342-2 20809251 10.1007/s11060-010-0342-2 1:CAS:528:DC%2BC3cXht1Sru77L
3. GA Alexiou P Gogou S Markoula AP Kyritsis 2010 Management of meningiomas Clin Neurol Neurosurg 112 177 182 10.1016/j.clineuro.2009.12.011 20056312 10.1016/j.clineuro.2009.12.011
4. PY Wen E Quant J Drappatz R Beroukhim AD Norden 2010 Medical therapies for meningiomas J Neurooncol 99 365 378 10.1007/s11060-010-0349-8 20820875 10.1007/s11060-010-0349-8 1:CAS:528:DC%2BC3cXht1Sru77E
5. S Hanft P Canoll JN Bruce 2010 A review of malignant meningiomas: diagnosis, characteristics, and treatment J Neurooncol 99 433 443 10.1007/s11060-010-0348-9 20730473 10.1007/s11060-010-0348-9 1:CAS:528:DC%2BC3cXht1Sru7%2FM
6. WP Mason F Gentili DR Macdonald S Hariharan CR Cruz LE Abrey 2002 Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma J Neurosurg 97 341 346 10.3171/jns.2002.97.2.0341 12186462 10.3171/jns.2002.97.2.0341 1:CAS:528:DC%2BD38XmsF2rtLs%3D (Pubitemid 34827334)
7. HB Newton 2007 Hydroxyurea chemotherapy in the treatment of meningiomas Neurosurg Focus 23 E11 17961035 10.3171/FOC-07/10/E11
8. HB Newton SR Scott C Volpi 2004 Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up Br J Neurosurg 18 495 499 15799152 10.1080/02688690400012392 1:STN:280:DC%2BD2M7mslahsQ%3D%3D (Pubitemid 40076195)
9. MA Rosenthal DL Ashley L Cher 2002 Treatment of high risk or recurrent meningiomas with hydroxyurea J Clin Neurosci 9 156 158 10.1054/jocn.2001. 1019S0967586801910197 11922703 10.1054/jocn.2001.1019 (Pubitemid 34464585)
10. D Loven R Hardoff ZB Sever AP Steinmetz M Gornish ZH Rappaport E Fenig Z Ram A Sulkes 2004 Non-resectable slow-growing meningiomas treated by hydroxyurea J Neurooncol 67 221 226 15072471 10.1023/B:NEON.0000021827.85754.8e (Pubitemid 38418272)
11. UM Schrell MG Rittig M Anders UH Koch R Marschalek F Kiesewetter R Fahlbusch 1997 Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea J Neurosurg 86 840 844 9126900 10.3171/jns.1997.86.5.0840 1:CAS:528:DyaK2sXms12ht70%3D (Pubitemid 27187687)
12. PY Wen WK Yung KR Lamborn AD Norden TF Cloughesy LE Abrey HA Fine SM Chang HI Robins K Fink LM Deangelis M Mehta E Di Tomaso J Drappatz S Kesari KL Ligon K Aldape RK Jain CD Stiles MJ Egorin MD Prados 2009 Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08) Neuro-oncology 11 853 860 10.1215/15228517-2009-010 19293394 10.1215/15228517-2009-010 1:CAS:528:DC%2BC3cXotVOruw%3D%3D
13. AD Norden JJ Raizer LE Abrey KR Lamborn AB Lassman SM Chang WK Yung MR Gilbert HA Fine M Mehta LM Deangelis TF Cloughesy HI Robins K Aldape J Dancey MD Prados F Lieberman PY Wen 2010 Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma J Neurooncol 96 211 217 10.1007/s11060-009- 9948-7 19562255 10.1007/s11060-009-9948-7 1:CAS:528:DC%2BC3cXpsVSjsw%3D%3D
14. J Folkman 1971 Tumor angiogenesis: therapeutic implications N Engl J Med 285 1182 1186 4938153 10.1056/NEJM197108122850711 1:STN:280: DyaE38%2FgvVCqsQ%3D%3D
15. DJ Hicklin LM Ellis 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J Clin Oncol 23 1011 1027 15585754 10.1200/JCO.2005.06.081 1:CAS:528:DC%2BD2MXit1Gnsro%3D (Pubitemid 46202320)
16. S Pistolesi L Boldrini S Gisfredi K De Ieso T Camacci M Caniglia G Lupi P Leocata F Basolo R Pingitore G Parenti G Fontanini 2004 Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study Neuropathol Appl Neurobiol 30 118 125 15043709 10.1046/j.0305-1846.2003.00516.x 1:STN:280:DC%2BD2c7lt1Snug%3D%3D (Pubitemid 38496702)
17. L Rogers M Gilbert MA Vogelbaum 2010 Intracranial meningiomas of atypical (WHO grade II) histology J Neurooncol 99 393 405 10.1007/s11060-010-0343-1 20740303 10.1007/s11060-010-0343-1
18. Cohen MH, Shen YL, Keegan P, Pazdur R (2009) FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. Oncologist 14:1131-1138
19. V Barresi G Tuccari 2009 Evaluation of neo-angiogenesis in a case of chordoid meningioma J Neurooncol 95 445 447 19557500 10.1007/s11060-009-9942-0
20. J Provias K Claffey L delAguila N Lau M Feldkamp A Guha 1997 Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema Neurosurgery 40 1016 1026 9149260 10.1097/00006123-199705000-00027 1:STN:280:DyaK2s3ptlartQ%3D%3D (Pubitemid 27202686)
21. F Maiuri MB De Caro F Esposito P Cappabianca V Strazzullo G Pettinato E de Divitiis 2007 Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors J Neurooncol 82 63 68 17225937 10.1007/s11060-005-9078-9
22. S Otsuka T Tamiya Y Ono H Michiue K Kurozumi S Daido H Kambara I Date T Ohmoto 2004 The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas J Neurooncol 70 349 357 15662977 10.1007/s11060-004-9164-4 (Pubitemid 40057964)
23. H Yoshioka S Hama E Taniguchi K Sugiyama K Arita K Kurisu 1999 Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply Cancer 85 936 944 10091773 10.1002/(SICI)1097-0142(19990215)85:4<936::AID-CNCR23>3.0.CO;2-J 1:STN:280:DyaK1M7ptVWqtg%3D%3D (Pubitemid 29077572)
24. BT Ragel RL Jensen 2010 Aberrant signaling pathways in meningiomas J Neurooncol 99 315 324 10.1007/s11060-010-0381-8 20838852 10.1007/s11060-010- 0381-8 1:CAS:528:DC%2BC3cXht1Sru77F
25. CK Goldman S Bharara CA Palmer J Vitek JC Tsai HL Weiss GY Gillespie 1997 Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression Neurosurgery 40 1269 1277 9179901 10.1097/00006123- 199706000-00029 1:STN:280:DyaK2szitlCmsQ%3D%3D (Pubitemid 27251680)
26. SN Kalkanis RS Carroll J Zhang AA Zamani PM Black 1996 Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas J Neurosurg 85 1095 1101 10.3171/jns.1996.85.6.1095 8929501 10.3171/jns.1996.85.6.1095 1:STN:280:DyaK2s%2FotlGnsQ%3D%3D (Pubitemid 26396565)
27. YS Ding HD Wang K Tang ZG Hu W Jin W Yan 2008 Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas Ann Clin Lab Sci 38 344 351 18988927 1:CAS:528:DC%2BD1cXhsVylt7jN
28. HS Friedman MD Prados PY Wen T Mikkelsen D Schiff LE Abrey WK Yung N Paleologos MK Nicholas R Jensen J Vredenburgh J Huang M Zheng T Cloughesy 2009 Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma J Clin Oncol 27 4733 4740 19720927 10.1200/JCO.2008.19.8721 1:CAS:528: DC%2BD1MXhtlGgtbbM
29. TN Kreisl L Kim K Moore P Duic C Royce I Stroud N Garren M Mackey JA Butman K Camphausen J Park PS Albert HA Fine 2009 Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma J Clin Oncol 27 740 745 19114704 10.1200/JCO.2008.16.3055 1:CAS:528:DC%2BD1MXjsVCjs7o%3D
30. PY Wen DR Macdonald DA Reardon TF Cloughesy AG Sorensen E Galanis J Degroot W Wick MR Gilbert AB Lassman C Tsien T Mikkelsen ET Wong MC Chamberlain R Stupp KR Lamborn MA Vogelbaum MJ van den Bent SM Chang 2010 Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 1963 1972 20231676 10.1200/JCO.2009.26.3541
31. MJ Puchner VH Hans A Harati F Lohmann M Glas U Herrlinger 2010 Bevacizumab-induced regression of anaplastic meningioma Ann Oncol 21 2445 2446 10.1093/annonc/mdq634 21041375 10.1093/annonc/mdq634 1:STN:280: DC%2BC3cbosF2mtA%3D%3D
32. DeBoer R, Grimm SA, Chandler J, Gallot L, Kennedy S, Burns K, Rice L, Cabreza C, Muro K, Raizer JJ (2008) A phase II trial of PTK-787 (PTK/ZK) in recurrent or progressive meningiomas. J Clin Oncol [2008 ASCO annual meeting proceedings (post-meeting edition)] 26:2060
33. DA Reardon AD Norden A Desjardins JJ Vredenburgh JE Herndon II A Coan JH Sampson S Gururangan KB Peters RE McLendon JA Norfleet ES Lipp J Drappatz PY Wen HS Friedman 2011 Phase II study of Gleevec((R)) plus hydroxyurea (HU) in adults with progressive or recurrent meningioma. J J Neurooncol 10.1007/s11060-011- 0687-1
34. MC Chamberlain SK Johnston 2011 Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series J Neurooncol 10.1007/s11060-011-0541-5
35. MC Chamberlain DD Tsao-Wei S Groshen 2006 Salvage chemotherapy with CPT-11 for recurrent meningioma J Neurooncol 78 271 276 16628476 10.1007/s11060-005-9093-x 1:CAS:528:DC%2BD28Xpt1ylt7g%3D
36. BM Hahn UM Schrell R Sauer R Fahlbusch O Ganslandt GG Grabenbauer 2005 Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study J Neurooncol 74 157 165 10.1007/s11060-004-2337-3 16193387 10.1007/s11060-004-2337-3 1:CAS:528:DC%2BD2MXht12hurjI (Pubitemid 41478912)
37. MC Chamberlain DD Tsao-Wei S Groshen 2004 Temozolomide for treatment-resistant recurrent meningioma Neurology 62 1210 1212 15079029 10.1212/01.WNL.0000118300.82017.F4 1:CAS:528:DC%2BD2cXktFGjtLo%3D (Pubitemid 38456523)
38. MC Chamberlain MJ Glantz 2008 Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas Cancer 113 2146 2151 18756531 10.1002/cncr.23803 1:CAS:528:DC%2BD1cXht12lu77I
39. DR Johnson DW Kimmel PA Burch TL Cascino C Giannini W Wu JC Buckner 2011 Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma Neuro Oncol 13 530 535 10.1093/neuonc/nor044 21558077 10.1093/neuonc/nor044 1:CAS:528: DC%2BC3MXovFWqtLo%3D
40. MC Chamberlain MJ Glantz CE Fadul 2007 Recurrent meningioma: salvage therapy with long-acting somatostatin analogue Neurology 69 969 973 17785665 10.1212/01.wnl.0000271382.62776.b7 1:CAS:528:DC%2BD2sXpsFaju78%3D (Pubitemid 47366049)
41. JW Goodwin J Crowley HJ Eyre B Stafford KA Jaeckle JJ Townsend 1993 A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study J Neurooncol 15 75 77 8455065 10.1007/BF01050266 1:STN:280:DyaK3s3gtl2htg%3D%3D (Pubitemid 23049702)
42. SM Grunberg C Rankin J Townsend, et al. 2001 Phase III double-blind randomized placebo-controlled study of mifepristone (RU) for the treatment of unreasectable meningioma Proc Am Soc Clin Oncol 20 222